SCHEMBL19929316

SCHEMBL19929316

COP(=O)(COCCn1cnc2c(N)nc(N)nc21)Oc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.45
FGFR1 P11362 2/20 0.45
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
POLA1 P09884 2/20 0.43
POLG P54098 2/20 0.43
ABCB11 O95342 1/20 0.43
FAP Q12884 1/20 0.43
SERPINA3 P01011 1/20 0.43
POLB P06746 4/20 0.42
TMIGD3 P0DMS9 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
NSD3 Q9BZ95 1/20 0.39
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
HSP90AA1 P07900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929313 0.87 FGFR1 (0.62) SLC22A6FGFR1POLA1POLGABCB11
SCHEMBL2734845 0.86 POLB (0.52) SLC22A6FGFR1CDK1CCNB1CCNE1
SCHEMBL17622587 0.84 POLB (0.60) POLA1POLGPOLB
SCHEMBL15532108 0.81 FGFR1 (0.67) SLC22A6FGFR1POLA1POLGABCB11
SCHEMBL8400651 0.80 CDK1 (0.53) SLC22A6FGFR1CDK1CCNB1CCNE1
SCHEMBL23394748 0.79 POLB (0.49) SLC22A6FGFR1POLA1POLGABCB11
SCHEMBL8400650 0.79 CDK1 (0.51) SLC22A6FGFR1CDK1CCNB1CCNE1
SCHEMBL2734810 0.78 FGFR1 (0.59) SLC22A6FGFR1CDK1CCNB1CCNE1
Pmedap SCHEMBL29571667 0.78 FGFR1 (0.72) SLC22A6FGFR1CDK1CCNB1CCNE1
Pmedap SCHEMBL215611 0.78 FGFR1 (0.72) SLC22A6FGFR1CDK1CCNB1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180064737-A1 ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS UNIV CALIFORNIA (US) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180064737-A1 ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS NTPCR, PNP, TYMP SLC22A6 1764/4885FGFR1 3394/4885CDK1 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.